is cd22 cancer
CD22 antigen is broadly expressed on lung cancer cells and is a target for antibody-based therapy.Tuscano JM, Kato J, Pearson D, Xiong C, Newell L, Ma Y, Gandara DR, O'Donnell RT. Most patients with lung cancer still die from their disease, necessitating additional options to improve treatment.Here, we provide evidence for targeting CD22, a cell adhesion protein known to influence B-cell survival that we found is also widely expressed in lung cancer cells.D22 antigen is broadly expressed on lung cancer cells and is a target for antibody-based therapy.